-
-
-
-
-
-
-
NovoCure reports $655 million 2025 revenue, up 8% from prior year
-
-
-
-
-
-
-
NovoCure gains health coverage in Spain for glioblastoma therapy
-
-
-
-
-
-
-
Piper Sandler Highlights 'Best Value Stocks' in Medical Technology
-
-
-
-
-
-
-
NovoCure Ltd. (NVCR) PT Raised to $42 at Piper Sandler 'Ahead of a New Set of Catalysts in 2025'
-
-
-
-
-
-
-
Novocure (NVCR) Tops Q3 EPS by 5c
-
-
-
-
-
-
-
NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

